| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An Agent-Based Approach to Dynamically Represent the Pharmacokinetic Properties of Baicalein
|
Zhu, Xiao
|
|
2016
|
18 |
6 |
p. 1475-1488
|
article
|
| 2 |
A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children
|
Lukacova, V.
|
|
2016
|
18 |
6 |
p. 1453-1463
|
article
|
| 3 |
A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products
|
Troiano, Greg
|
|
2016
|
18 |
6 |
p. 1354-1365
|
article
|
| 4 |
Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution Profiles
|
Mangas-Sanjuan, Victor
|
|
2016
|
18 |
6 |
p. 1550-1561
|
article
|
| 5 |
Best Practices in Stability Indicating Method Development and Validation for Non-clinical Dose Formulations
|
Henry, Teresa R.
|
|
2016
|
18 |
6 |
p. 1418-1423
|
article
|
| 6 |
Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance
|
Argikar, Upendra A.
|
|
2016
|
18 |
6 |
p. 1391-1405
|
article
|
| 7 |
Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin
|
Olivares-Morales, Andrés
|
|
2016
|
18 |
6 |
p. 1532-1549
|
article
|
| 8 |
Erratum to: Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors
|
Feng, Zhiwei
|
|
2016
|
18 |
6 |
p. 1585
|
article
|
| 9 |
Erratum to: Does the Recent Growth of Aquaculture Create Antibiotic Resistance Threats Different from those Associated with Land Animal Production in Agriculture?
|
Done, Hansa Y.
|
|
2016
|
18 |
6 |
p. 1583
|
article
|
| 10 |
Erratum to: Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin
|
Martinez, Marilyn
|
|
2016
|
18 |
6 |
p. 1584
|
article
|
| 11 |
Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics
|
Jawa, Vibha
|
|
2016
|
18 |
6 |
p. 1439-1452
|
article
|
| 12 |
Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry
|
Feasel, Michael G.
|
|
2016
|
18 |
6 |
p. 1489-1499
|
article
|
| 13 |
Nanomedicines: From Bench to Bedside and Beyond
|
Havel, Henry
|
|
2016
|
18 |
6 |
p. 1373-1378
|
article
|
| 14 |
Nanomedicines in the EU—Regulatory Overview
|
Pita, Ruben
|
|
2016
|
18 |
6 |
p. 1576-1582
|
article
|
| 15 |
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
|
Savolainen, Heli
|
|
2016
|
18 |
6 |
p. 1524-1531
|
article
|
| 16 |
Physiologically Based Absorption Modeling to Design Extended-Release Clinical Products for an Ester Prodrug
|
Ding, Xuan
|
|
2016
|
18 |
6 |
p. 1424-1438
|
article
|
| 17 |
Physiologically Based Absorption Modeling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of Alectinib
|
Parrott, Neil J
|
|
2016
|
18 |
6 |
p. 1464-1474
|
article
|
| 18 |
Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug Applications
|
Suarez-Sharp, Sandra
|
|
2016
|
18 |
6 |
p. 1379-1390
|
article
|
| 19 |
Scientific and Regulatory Considerations in Solid Oral Modified Release Drug Product Development
|
Li, Min
|
|
2016
|
18 |
6 |
p. 1406-1417
|
article
|
| 20 |
Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics
|
Wu, Bonnie
|
|
2016
|
18 |
6 |
p. 1335-1350
|
article
|
| 21 |
The Dual Role of Lipids of the Lipoproteins in Trumenba, a Self-Adjuvanting Vaccine Against Meningococcal Meningitis B Disease
|
Luo, Yin
|
|
2016
|
18 |
6 |
p. 1562-1575
|
article
|
| 22 |
Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses
|
Chow, Edwin Chiu Yuen
|
|
2016
|
18 |
6 |
p. 1500-1511
|
article
|
| 23 |
Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling
|
Zhu, Andy Z. X.
|
|
2016
|
18 |
6 |
p. 1512-1523
|
article
|
| 24 |
Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials
|
Havel, Henry A.
|
|
2016
|
18 |
6 |
p. 1351-1353
|
article
|
| 25 |
Workshop Report: Crystal City VI—Bioanalytical Method Validation for Biomarkers
|
Arnold, Mark E.
|
|
2016
|
18 |
6 |
p. 1366-1372
|
article
|
Journal description